LLYs - healthylife7.com

Browsing: LLYs

LLY’s Retatrutide Nears 2027 Filing With Two More Phase III Wins

By healthylife7July 24, 20260

Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating its next-generation, experimental triple-acting incretin, retatrutide, in patients with obesity or those who are overweight as well as some of its most serious complications – type II diabetes and established cardiovascular disease

What's Hot

How daily habits and primary care can protect your brain health as you age

Chronic Illness Is the New Rite of Passage in Motherhood

Almost in Love, and AI’s Limits of “Close Enough”

Browsing: LLYs

LLY’s Retatrutide Nears 2027 Filing With Two More Phase III Wins

How daily habits and primary care can protect your brain health as you age

Chronic Illness Is the New Rite of Passage in Motherhood

Almost in Love, and AI’s Limits of “Close Enough”

LeBron James starts Day 24 of free agency sweepstakes with Instagram workout

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

How daily habits and primary care can protect your brain health as you age

Chronic Illness Is the New Rite of Passage in Motherhood

Almost in Love, and AI’s Limits of “Close Enough”

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: LLYs